The post is funded by the NIHR and will allow Rebecca to spend 50% of her time doing research within the university and the other 50% working clinically at the hospital. She will use her academic time to develop a model of global myocardial ischaemia to further personalise treatment decisions in patients with coronary artery disease.
We look forward to welcoming Rebecca back in March 2021, on her return from maternity leave, and would like to take this opportunity to thank her for her time served on the Insigneo Board as Interim Director of Clinical Translation during 2018-2019 while Dr Paul Morris was away from 91Ö±²¥ working at the Royal Jubilee Hospital in British Columbia, Canada doing a British Cardiovascular Intervention Society and Boston Scientific fellowship in coronary intervention.